Contribution of TRPC3-mediated Ca2+ entry to taste transduction

Cherkashin, Alexander P.; Rogachevskaja, Olga A.; Хохлов, А. А.; Kabanova, N. V.; Bystrova, M. F.; Kolesnikov, Stanislav S.

doi:10.1007/s00424-023-02834-8

Cited by 2 publications

(1 citation statement)

References 74 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, there is a paper revealing that ATP6V1C2 alone is a prognostic factor in COAD ( 69 ). Interestingly, TRPM5 has a role in taste transduction ( 70 ). It is also involved in metabolic disorders ( 71 ).…”

Section: Discussionmentioning

confidence: 99%

PANoptosis-related genes function as efficient prognostic biomarkers in colon adenocarcinoma

Liu,

Wang,

Feng

et al. 2024

Front. Endocrinol.

View full text Add to dashboard Cite

BackgroundPANoptosis is a newly discovered cell death type, and tightly associated with immune system activities. To date, the mechanism, regulation and application of PANoptosis in tumor is largely unknown. Our aim is to explore the prognostic value of PANoptosis-related genes in colon adenocarcinoma (COAD).MethodsAnalyzing data from The Cancer Genome Atlas-COAD (TCGA-COAD) involving 458 COAD cases, we concentrated on five PANoptosis pathways from the Molecular Signatures Database (MSigDB) and a comprehensive set of immune-related genes. Our approach involved identifying distinct genetic COAD subtype clusters and developing a prognostic model based on these parameters.ResultsThe research successfully identified two genetic subtype clusters in COAD, marked by distinct profiles in PANoptosis pathways and immune-related gene expression. A prognostic model, incorporating these findings, demonstrated significant predictive power for survival outcomes, underscoring the interplay between PANoptosis and immune responses in COAD.ConclusionThis study enhances our understanding of COAD’s genetic framework, emphasizing the synergy between cell death pathways and the immune system. The development of a prognostic model based on these insights offers a promising tool for personalized treatment strategies. Future research should focus on validating and refining this model in clinical settings to optimize therapeutic interventions in COAD.

show abstract

Section: Discussionmentioning

confidence: 99%